Alere was founded in 1991 by Ron Zwanziger as SelfCare, SelfCare went public in 1996 and changed its name to Inverness Medical Technology (IMT) in 2000.
In 2001 the company sold its diabetes business to Johnson & Johnson and began to expand its remaining business through acquisitions of companies such as Wampole Laboratories, Ostex International, Binax, and Axis-Shield.
In 2004 the company launched the world’s first digital pregnancy test with Clearblue Digital Pregnancy Test.
Today Alere, as the company has been known since 2010, offers professional and consumer diagnostic tests, including tests for cancer, cardiovascular disease, drug abuse, infectious disease, lipid and cholesterol, HIV, tuberculosis, hepatitis B, and women’s health including pregnancy tests and fertility monitors.
Alere trades publicly on the New York Stock Exchange under the ticker symbol ALR, is #725 in the Fortune 1000, has 17,600 employees, and had $2.96 billion in revenue in 2014.
AlereAlere was founded in 1991 by Ron Zwanziger as SelfCare, SelfCare went public in 1996 and changed its name to Inverness Medical Technology (IMT) in 2000.
In 2001 the company sold its diabetes business to Johnson & Johnson and began to expand its remaining business through acquisitions of companies such as Wampole Laboratories, Ostex International, Binax, and Axis-Shield.
In 2004 the company launched the world’s first digital pregnancy test with Clearblue Digital Pregnancy Test.
History
Today Alere, as the company has been known since 2010, offers professional and consumer diagnostic tests, including tests for cancer, cardiovascular disease, drug abuse, infectious disease, lipid and cholesterol, HIV, tuberculosis, hepatitis B, and women’s health including pregnancy tests and fertility monitors.
Alere trades publicly on the New York Stock Exchange under the ticker symbol ALR, is #725 in the Fortune 1000, has 17,600 employees, and had $2.96 billion in revenue in 2014.